148 related articles for article (PubMed ID: 12905639)
21. Increased intrathecal TGF-beta1, but not IL-12, IFN-gamma and IL-10 levels in Alzheimer's disease patients.
Rota E; Bellone G; Rocca P; Bergamasco B; Emanuelli G; Ferrero P
Neurol Sci; 2006 Apr; 27(1):33-9. PubMed ID: 16688597
[TBL] [Abstract][Full Text] [Related]
22. Significant correlation of matrix metalloproteinase and macrophage colony-stimulating factor serum concentrations in patients with head and neck cancer.
Kuropkat C; Duenne AA; Herz U; Renz H; Werner JA
Neoplasma; 2004; 51(5):375-8. PubMed ID: 15640942
[TBL] [Abstract][Full Text] [Related]
23. [Selected hematopoietic cytokines in patients with colorectal cancer].
Mroczko B; Ławicki S; Szmitkowski M; Czygier M; Okulczyk B; Piotrowski Z
Pol Merkur Lekarski; 2003 Nov; 15(89):416-9. PubMed ID: 14969133
[TBL] [Abstract][Full Text] [Related]
24. Soluble interleukin-1 receptor type II, IL-18 and caspase-1 in mild cognitive impairment and severe Alzheimer's disease.
Lindberg C; Chromek M; Ahrengart L; Brauner A; Schultzberg M; Garlind A
Neurochem Int; 2005 Jun; 46(7):551-7. PubMed ID: 15843049
[TBL] [Abstract][Full Text] [Related]
25. Low serum VEGF levels are associated with Alzheimer's disease.
Mateo I; Llorca J; Infante J; Rodríguez-Rodríguez E; Fernández-Viadero C; Peña N; Berciano J; Combarros O
Acta Neurol Scand; 2007 Jul; 116(1):56-8. PubMed ID: 17587256
[TBL] [Abstract][Full Text] [Related]
26. Macrophage colony-stimulating factor as a marker for malignant germ cell tumors of the ovary.
Suzuki M; Kobayashi H; Ohwada M; Terao T; Sato I
Gynecol Oncol; 1998 Jan; 68(1):35-7. PubMed ID: 9454657
[TBL] [Abstract][Full Text] [Related]
27. Serum macrophage colony-stimulating factor (M-CSF) levels in patients with epithelial ovarian cancer.
Gadducci A; Ferdeghini M; Castellani C; Annicchiarico C; Prontera C; Facchini V; Bianchi R; Genazzani AR
Gynecol Oncol; 1998 Jul; 70(1):111-4. PubMed ID: 9698485
[TBL] [Abstract][Full Text] [Related]
28. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
[TBL] [Abstract][Full Text] [Related]
29. Lipids' peroxidation markers in Alzheimer's disease and vascular dementia.
Gustaw-Rothenberg K; Kowalczuk K; Stryjecka-Zimmer M
Geriatr Gerontol Int; 2010 Apr; 10(2):161-6. PubMed ID: 20446930
[TBL] [Abstract][Full Text] [Related]
30. [Comparative study on the clinical features of Alzheimer's disease and vascular dementia].
Chen X; Zhang ZX; Huang JB; Wen HB
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):122-7. PubMed ID: 15171546
[TBL] [Abstract][Full Text] [Related]
31. Increased midkine levels in sera from patients with Alzheimer's disease.
Salama RH; Muramatsu H; Shimizu E; Hashimoto K; Ohgake S; Watanabe H; Komatsu N; Okamura N; Koike K; Shinoda N; Okada S; Iyo M; Muramatsu T
Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):611-6. PubMed ID: 15866365
[TBL] [Abstract][Full Text] [Related]
32. Cerebrospinal fluid tau, Abeta1-42 and inflammatory cytokines in patients with Alzheimer's disease and vascular dementia.
Jia JP; Meng R; Sun YX; Sun WJ; Ji XM; Jia LF
Neurosci Lett; 2005 Jul 22-29; 383(1-2):12-6. PubMed ID: 15936505
[TBL] [Abstract][Full Text] [Related]
33. Neuropsychological and behavioural correlates of CSF biomarkers in dementia.
Engelborghs S; Maertens K; Vloeberghs E; Aerts T; Somers N; Mariën P; De Deyn PP
Neurochem Int; 2006 Mar; 48(4):286-95. PubMed ID: 16434124
[TBL] [Abstract][Full Text] [Related]
34. Elevated levels of macrophage colony-stimulating factor in human fracture healing.
Sarahrudi K; Mousavi M; Thomas A; Eipeldauer S; Vécsei V; Pietschmann P; Aharinejad S
J Orthop Res; 2010 May; 28(5):671-6. PubMed ID: 19950360
[TBL] [Abstract][Full Text] [Related]
35. The effect of inflammatory cytokines on secretion of macrophage colony-stimulating factor and monocyte chemoattractant protein-1 in human granulosa cells.
Kawano Y; Fukuda J; Itoh H; Takai N; Nasu K; Miyakawa I
Am J Reprod Immunol; 2004 Aug; 52(2):124-8. PubMed ID: 15274652
[TBL] [Abstract][Full Text] [Related]
36. Plasma cytokines profile in older subjects with late onset Alzheimer's disease or vascular dementia.
Zuliani G; Ranzini M; Guerra G; Rossi L; Munari MR; Zurlo A; Volpato S; Atti AR; Blè A; Fellin R
J Psychiatr Res; 2007 Oct; 41(8):686-93. PubMed ID: 16600299
[TBL] [Abstract][Full Text] [Related]
37. Elevated interleukin-6 levels in cerebrospinal fluid of vascular dementia patients.
Wada-Isoe K; Wakutani Y; Urakami K; Nakashima K
Acta Neurol Scand; 2004 Aug; 110(2):124-7. PubMed ID: 15242421
[TBL] [Abstract][Full Text] [Related]
38. Relationship between serum insulin-like growth factor-1 levels and Alzheimer's disease and vascular dementia.
Watanabe T; Miyazaki A; Katagiri T; Yamamoto H; Idei T; Iguchi T
J Am Geriatr Soc; 2005 Oct; 53(10):1748-53. PubMed ID: 16181175
[TBL] [Abstract][Full Text] [Related]
39. Serum TNF-alpha levels are increased and correlate negatively with free IGF-I in Alzheimer disease.
Alvarez A; Cacabelos R; Sanpedro C; García-Fantini M; Aleixandre M
Neurobiol Aging; 2007 Apr; 28(4):533-6. PubMed ID: 16569464
[TBL] [Abstract][Full Text] [Related]
40. Plasma aminothiol compounds, but not serum tumor necrosis factor receptor II and soluble receptor for advanced glycation end products, are related to the cognitive impairment in Alzheimer's disease and mild cognitive impairment patients.
Hernanz A; De la Fuente M; Navarro M; Frank A
Neuroimmunomodulation; 2007; 14(3-4):163-7. PubMed ID: 18073509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
